Search research articles
Contact Us
Filters
Showing results (51-60 of 235) with videos related to
Page
of 24
Sort By:
The EMBO Journal
|
March 1, 1986
Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator
M Seiki, J Inoue, T Takeda, et al.
The EMBO Journal
|
April 1, 1986
A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I
J Fujisawa, M Seiki, M Sato, et al.
The EMBO Journal
|
February 1, 1988
Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins
M Hidaka, J Inoue, M Yoshida, et al.
Science (New York, N.Y.)
|
June 28, 1985
Expression of the pX gene of HTLV-I: general splicing mechanism in the HTLV family
M Seiki, A Hikikoshi, T Taniguchi, et al.
Biochemical and Biophysical Research Communications
|
February 16, 2000
Human membrane type-2 matrix metalloproteinase is defective in cell-associated activation of progelatinase A
H Miyamori, T Takino, M Seiki, et al.
Annals of the New York Academy of Sciences
|
July 23, 1999
Transient increase of intracellular cAMP by heat shock initiates the suppression of MT1-MMP production in tumor cells
Y Sawaji, T Sato, M Seiki, et al.
The Journal of Biological Chemistry
|
January 13, 1995
The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation
J Cao, H Sato, T Takino, et al.
Gene
|
April 3, 1995
Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain
T Takino, H Sato, E Yamamoto, et al.
Cancer Research
|
August 1, 1995
Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells
M Yu, H Sato, M Seiki, et al.
International Journal of Cancer
|
November 11, 1991
Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: human melanoma and ras-transfected NIH3T3 cells
M Seiki, H Sato, L A Liotta, et al.
Page
of 24
Search research articles
Search
Showing results (51-60 of 235) with videos related to
Sort By:
Page
of 24
The EMBO Journal
|
March 1, 1986
Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator
M Seiki, J Inoue, T Takeda, et al.
The EMBO Journal
|
April 1, 1986
A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I
J Fujisawa, M Seiki, M Sato, et al.
The EMBO Journal
|
February 1, 1988
Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins
M Hidaka, J Inoue, M Yoshida, et al.
Science (New York, N.Y.)
|
June 28, 1985
Expression of the pX gene of HTLV-I: general splicing mechanism in the HTLV family
M Seiki, A Hikikoshi, T Taniguchi, et al.
Biochemical and Biophysical Research Communications
|
February 16, 2000
Human membrane type-2 matrix metalloproteinase is defective in cell-associated activation of progelatinase A
H Miyamori, T Takino, M Seiki, et al.
Annals of the New York Academy of Sciences
|
July 23, 1999
Transient increase of intracellular cAMP by heat shock initiates the suppression of MT1-MMP production in tumor cells
Y Sawaji, T Sato, M Seiki, et al.
The Journal of Biological Chemistry
|
January 13, 1995
The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation
J Cao, H Sato, T Takino, et al.
Gene
|
April 3, 1995
Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain
T Takino, H Sato, E Yamamoto, et al.
Cancer Research
|
August 1, 1995
Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells
M Yu, H Sato, M Seiki, et al.
International Journal of Cancer
|
November 11, 1991
Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: human melanoma and ras-transfected NIH3T3 cells
M Seiki, H Sato, L A Liotta, et al.
Page
of 24